ArticleMolecular medicine reports2019

Homoharringtonine enhances the effect of imatinib on chronic myelogenous leukemia cells by downregulating ZFX.

Jingjing Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.